NO20012916D0 - Sammensetninger og fremgangsmåter for behandling av anorektale forstyrrelser - Google Patents
Sammensetninger og fremgangsmåter for behandling av anorektale forstyrrelserInfo
- Publication number
- NO20012916D0 NO20012916D0 NO20012916A NO20012916A NO20012916D0 NO 20012916 D0 NO20012916 D0 NO 20012916D0 NO 20012916 A NO20012916 A NO 20012916A NO 20012916 A NO20012916 A NO 20012916A NO 20012916 D0 NO20012916 D0 NO 20012916D0
- Authority
- NO
- Norway
- Prior art keywords
- compositions
- methods
- anorectal disorders
- treating anorectal
- treating
- Prior art date
Links
- 208000015815 Rectal disease Diseases 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
- A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11232598P | 1998-12-14 | 1998-12-14 | |
US13991699P | 1999-06-17 | 1999-06-17 | |
US15531899P | 1999-09-21 | 1999-09-21 | |
PCT/US1999/029459 WO2000035434A2 (en) | 1998-12-14 | 1999-12-13 | Compositions and methods for the treatment of anorectal disorders |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20012916D0 true NO20012916D0 (no) | 2001-06-13 |
NO20012916L NO20012916L (no) | 2001-08-14 |
Family
ID=27381146
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20012916A NO20012916L (no) | 1998-12-14 | 2001-06-13 | Sammensetninger og fremgangsmåter for behandling av anorektale forstyrrelser |
Country Status (14)
Country | Link |
---|---|
US (2) | US6395736B1 (no) |
EP (1) | EP1143956A3 (no) |
JP (1) | JP2002542147A (no) |
KR (1) | KR20010093828A (no) |
CN (2) | CN1526448A (no) |
AU (1) | AU764921B2 (no) |
BR (1) | BR9916162A (no) |
CA (1) | CA2354543A1 (no) |
CZ (1) | CZ20012113A3 (no) |
HU (1) | HUP0104676A3 (no) |
IL (1) | IL143726A0 (no) |
NO (1) | NO20012916L (no) |
PL (1) | PL348817A1 (no) |
WO (1) | WO2000035434A2 (no) |
Families Citing this family (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9801398D0 (en) | 1998-01-22 | 1998-03-18 | Anggard Erik E | Chemical compounds |
US6627632B2 (en) * | 1998-12-14 | 2003-09-30 | Cellegy Pharmaceuticals, Inc. | Compositions and methods for the treatment of anorectal disorders |
GB9924636D0 (en) * | 1999-10-18 | 1999-12-22 | Norgine Bv | Laxative preparation |
ATE369359T1 (de) * | 2000-02-15 | 2007-08-15 | Sugen Inc | Pyrrol substituierte indolin-2-on protein kinase inhibitoren |
AU2001279104A1 (en) * | 2000-07-31 | 2002-02-13 | Cellegy Pharmaceuticals, Inc. | Compositions and methods for the treatment of anorectal disorders |
GB0020588D0 (en) * | 2000-08-21 | 2000-10-11 | Pfizer Ltd | Treatment of wounds |
WO2002022127A1 (en) * | 2000-09-13 | 2002-03-21 | Isis Innovation Limited | Use of phosphodiesterase inhibitors for the treatment of anorectal disorders |
AR042586A1 (es) | 2001-02-15 | 2005-06-29 | Sugen Inc | 3-(4-amidopirrol-2-ilmetiliden)-2-indolinona como inhibidores de la protein quinasa; sus composiciones farmaceuticas; un metodo para la modulacion de la actividad catalitica de la proteinquinasa; un metodo para tratar o prevenir una afeccion relacionada con la proteinquinasa |
DE10118306A1 (de) * | 2001-04-12 | 2002-10-17 | Bayer Ag | Imidazotriazinonhaltige Zusammensetzungen zur nasalen Applikation |
DE10118305A1 (de) * | 2001-04-12 | 2002-10-17 | Bayer Ag | Zusammensetzungen zur nasalen Applikation |
EP1414841B1 (en) | 2001-07-10 | 2012-11-14 | Lakewood-Amedex, Inc | Oligonucleotide-containing pharmacological compositions and their use |
WO2003022239A2 (en) * | 2001-09-07 | 2003-03-20 | Western Holdings Llc | Stable water in oil aminophylline emulsions |
BR0213185A (pt) | 2001-10-10 | 2004-09-14 | Sugen Inc | Derivados de 3-[4-(heterociclila substituìda)-pirrol-2-ilmetilideno]2-indolinona como inibidores de cinase |
JP4563679B2 (ja) * | 2001-12-06 | 2010-10-13 | デューク ユニバーシティ | 形成外科における組織弁壊死の予防 |
AU2003213787A1 (en) * | 2002-03-06 | 2003-09-22 | Cellegy Pharmaceuticals, Inc. | Compositions and methods for the treatment of anorectal disorders |
US7378438B2 (en) | 2002-04-19 | 2008-05-27 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Beta-agonist compounds comprising nitric oxide donor groups and reactive oxygen species scavenger groups and their use in the treatment of respiratory disorders |
US20040147534A1 (en) * | 2003-01-23 | 2004-07-29 | Foote Mary Ann | Topical composition and method for treating occlusive wounds |
US6863825B2 (en) | 2003-01-29 | 2005-03-08 | Union Oil Company Of California | Process for removing arsenic from aqueous streams |
US7220422B2 (en) * | 2003-05-20 | 2007-05-22 | Allergan, Inc. | Methods and compositions for treating eye disorders |
US20050089559A1 (en) * | 2003-10-23 | 2005-04-28 | Istvan Szelenyi | Combinations of potassium channel openers and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains |
DE10352132A1 (de) * | 2003-11-04 | 2005-06-09 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pharmazeutische Zusammensetzung aus einem Beta-3-Adrenozeptor-Agonisten und einem Alpha Agonisten |
US20060147504A1 (en) * | 2004-12-30 | 2006-07-06 | Bobby Corry | Feminine anti-itch cloth |
US8252308B2 (en) * | 2005-01-27 | 2012-08-28 | C.B. Fleet Company Inc. | Feminine anti-itch gel |
WO2006084913A2 (en) * | 2005-02-11 | 2006-08-17 | Nolabs Ab | Device for treatment of rectal disorders, and manufacturing process for the same, involving nitric oxide |
CA2635337C (en) * | 2005-12-30 | 2015-02-17 | Nir Barak | Device for treating the anal sphincter |
CN103172592B (zh) * | 2006-01-05 | 2016-01-06 | 伊森舍丽斯有限公司 | 钾atp 通道开放剂的盐及其用途 |
US7960436B2 (en) * | 2006-06-05 | 2011-06-14 | Valeant Pharmaceuticals International | Substituted arylamino-1,2,3,4-tetrahydro naphthalenes and-2,3-dihydro-1H-indenes as potassium channel modulators |
US20080045534A1 (en) * | 2006-08-18 | 2008-02-21 | Valeant Pharmaceuticals North America | Derivatives of 1,3-diamino benzene as potassium channel modulators |
PT2061465E (pt) * | 2006-08-23 | 2013-07-15 | Valeant Pharmaceuticals Int | Derivados de 4-(n-azacicloalquil)anilidas como moduladores do canal de potássio |
US8993593B2 (en) * | 2006-08-23 | 2015-03-31 | Valeant Pharmaceuticals International | N-(4-(6-fluoro-3,4-dihydroisoquinolin-2(1H)-yl)-2,6-dimethylphenyl)-3,3-dimethylbutanamide as potassium channel modulators |
US8722929B2 (en) * | 2006-10-10 | 2014-05-13 | Valeant Pharmaceuticals International | N-[2-amino-4-(phenylmethoxy)phenyl] amides and related compounds as potassium channel modulators |
KR20090083479A (ko) * | 2006-11-28 | 2009-08-03 | 밸리언트 파마슈티컬즈 인터내셔널 | 칼륨 채널 조절제로서의 1,4 디아미노 이환 레티가빈 유사체 |
US8066874B2 (en) | 2006-12-28 | 2011-11-29 | Molycorp Minerals, Llc | Apparatus for treating a flow of an aqueous solution containing arsenic |
US8367684B2 (en) * | 2007-06-13 | 2013-02-05 | Valeant Pharmaceuticals International | Derivatives of 4-(N-azacycloalkyl) anilides as potassium channel modulators |
US8563566B2 (en) | 2007-08-01 | 2013-10-22 | Valeant Pharmaceuticals International | Naphthyridine derivatives as potassium channel modulators |
US7786146B2 (en) * | 2007-08-13 | 2010-08-31 | Valeant Pharmaceuticals International | Derivatives of 5-amino-4,6-disubstituted indole and 5-amino-4,6-disubstituted indoline as potassium channel modulators |
US8252087B2 (en) | 2007-10-31 | 2012-08-28 | Molycorp Minerals, Llc | Process and apparatus for treating a gas containing a contaminant |
US8349764B2 (en) | 2007-10-31 | 2013-01-08 | Molycorp Minerals, Llc | Composition for treating a fluid |
EP2445481B1 (en) | 2009-06-18 | 2017-03-22 | Rdd Pharma Ltd. | Methods and devices for delivery of pharmaceutical agents within orifices of the body |
US8778969B2 (en) * | 2009-11-07 | 2014-07-15 | Peter H Proctor | Nitrone, nitroso, and nitroxide spintraps and spin labels and their hydroxylamines |
EP2512479B1 (en) * | 2009-12-18 | 2016-03-30 | Exodos Life Sciences Limited Partnership | Compositions for treating peripheral vascular disease |
CN102145004B (zh) * | 2010-02-09 | 2012-03-21 | 鲁南制药集团股份有限公司 | 己酮可可碱在制备预防或治疗功能性便秘的药物中的用途 |
WO2011127586A1 (en) * | 2010-04-15 | 2011-10-20 | The Royal Institution For The Advancement Of Learning / Mcgill University | Topical treatments for pain |
US9233863B2 (en) | 2011-04-13 | 2016-01-12 | Molycorp Minerals, Llc | Rare earth removal of hydrated and hydroxyl species |
WO2013090681A2 (en) | 2011-12-16 | 2013-06-20 | The Regents Of The University Of Michigan | Digital manometry finger-mountable sensor device |
CN103393690B (zh) * | 2013-08-01 | 2016-05-11 | 南通大学附属医院 | Katp通道开放剂在制备治疗术后疼痛药物中的应用 |
US10064871B2 (en) | 2014-01-22 | 2018-09-04 | Biomimetix Jv, Llc | Methods of treating skin disorders |
WO2015112586A1 (en) * | 2014-01-22 | 2015-07-30 | Duke University | Methods of treating pruritus |
CA2941859A1 (en) | 2014-03-07 | 2015-09-11 | Molycorp Minerals, Llc | Cerium (iv) oxide with exceptional arsenic removal properties |
RU2595799C1 (ru) * | 2015-05-14 | 2016-08-27 | Светлана Николаевна Суслина | Композиция для лечения анальных трещин в форме крема |
WO2017168174A1 (en) | 2016-04-02 | 2017-10-05 | N4 Pharma Uk Limited | New pharmaceutical forms of sildenafil |
MX2020012949A (es) * | 2018-06-01 | 2021-05-12 | Tavanta Therapeutics Hungary Incorporated | Sales tópicas de amlodipino para el tratamiento de enfermedades anorrectales. |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4117249C2 (de) * | 1991-05-27 | 1998-05-14 | Christian Dr Stief | Linsidomin zur Behandlung erektiler Dysfunktionen |
GB9119467D0 (en) * | 1991-09-12 | 1991-10-23 | Smithkline Beecham Corp | Chemical compounds |
US5234947A (en) * | 1991-11-07 | 1993-08-10 | New York University | Potassium channel activating compounds and methods of use thereof |
ZA941027B (en) * | 1993-02-16 | 1994-11-11 | Smithkline Beecham Corp | Chemical compounds |
WO1994022460A1 (en) * | 1993-04-05 | 1994-10-13 | University Patents, Inc. | Diagnosis and treatment of erectile dysfunction |
US5948762A (en) * | 1993-07-16 | 1999-09-07 | Schering Aktiengesellschaft | Treatment of uterine contractility disorders with a nitric oxide synthase substrate and/or donor or a nitric oxide inhibitor |
WO1995006466A1 (en) * | 1993-09-01 | 1995-03-09 | Koren Laboratories Pty. Limited | Treatment of anorectal disorders |
DE69535607T2 (de) * | 1994-05-27 | 2008-07-10 | Strakan International Ltd. | Zusammensetzung enthaltend Stickstoffoxid-donatoren und Methode zur Behandlung analer Krankheiten |
US5932538A (en) * | 1996-02-02 | 1999-08-03 | Nitromed, Inc. | Nitrosated and nitrosylated α-adrenergic receptor antagonist compounds, compositions and their uses |
US5994294A (en) * | 1996-02-02 | 1999-11-30 | Nitromed, Inc. | Nitrosated and nitrosylated α-adrenergic receptor antagonist compounds, compositions and their uses |
JP2001504457A (ja) * | 1996-11-01 | 2001-04-03 | ニトロメド インコーポレーテッド | ニトロソ化およびニトロシル化ホスホジエステラーゼ阻害剤化合物、組成物及びその使用法 |
PT946155E (pt) * | 1996-12-23 | 2006-07-31 | Sla Pharma Ag | Composicao farmaceutica para tratar incontinencia fecal e prurido anal |
NZ506596A (en) * | 1998-02-27 | 2003-10-31 | Synchroneuron Llc | Compositions comprising an alpha1-adrenergic antagonist, sucralfate and a local anaesthetic and further comprising nitroglycerin |
EP1123296B1 (en) * | 1998-10-23 | 2003-09-17 | Pfizer Limited | PYRAZOLOPYRIMIDINONE cGMP PDE5 INHIBITORS FOR THE TREATMENT OF SEXUAL DYSFUNCTION |
-
1999
- 1999-12-13 CN CNA200410008292XA patent/CN1526448A/zh active Pending
- 1999-12-13 EP EP99966154A patent/EP1143956A3/en not_active Withdrawn
- 1999-12-13 PL PL99348817A patent/PL348817A1/xx unknown
- 1999-12-13 BR BR9916162-1A patent/BR9916162A/pt not_active Application Discontinuation
- 1999-12-13 CZ CZ20012113A patent/CZ20012113A3/cs unknown
- 1999-12-13 WO PCT/US1999/029459 patent/WO2000035434A2/en not_active Application Discontinuation
- 1999-12-13 US US09/460,306 patent/US6395736B1/en not_active Expired - Fee Related
- 1999-12-13 HU HU0104676A patent/HUP0104676A3/hu unknown
- 1999-12-13 AU AU21763/00A patent/AU764921B2/en not_active Ceased
- 1999-12-13 CA CA002354543A patent/CA2354543A1/en not_active Abandoned
- 1999-12-13 CN CNB998144304A patent/CN1149983C/zh not_active Expired - Fee Related
- 1999-12-13 IL IL14372699A patent/IL143726A0/xx unknown
- 1999-12-13 JP JP2000587755A patent/JP2002542147A/ja active Pending
- 1999-12-13 KR KR1020017007394A patent/KR20010093828A/ko not_active Application Discontinuation
-
2001
- 2001-01-23 US US09/769,621 patent/US20010012856A1/en not_active Abandoned
- 2001-06-13 NO NO20012916A patent/NO20012916L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU2176300A (en) | 2000-07-03 |
BR9916162A (pt) | 2001-09-04 |
CN1149983C (zh) | 2004-05-19 |
HUP0104676A3 (en) | 2005-12-28 |
CN1526448A (zh) | 2004-09-08 |
JP2002542147A (ja) | 2002-12-10 |
WO2000035434A2 (en) | 2000-06-22 |
KR20010093828A (ko) | 2001-10-29 |
CN1330539A (zh) | 2002-01-09 |
US20010012856A1 (en) | 2001-08-09 |
AU764921B2 (en) | 2003-09-04 |
EP1143956A2 (en) | 2001-10-17 |
CZ20012113A3 (cs) | 2001-11-14 |
NO20012916L (no) | 2001-08-14 |
WO2000035434A3 (en) | 2000-11-30 |
PL348817A1 (en) | 2002-06-17 |
CA2354543A1 (en) | 2000-06-22 |
HUP0104676A2 (en) | 2002-06-29 |
US6395736B1 (en) | 2002-05-28 |
EP1143956A3 (en) | 2001-12-12 |
IL143726A0 (en) | 2002-04-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20012916D0 (no) | Sammensetninger og fremgangsmåter for behandling av anorektale forstyrrelser | |
NO20003096D0 (no) | Sammensetninger og fremgangsmÕter for behandling av ADD | |
DK1109453T3 (da) | Sammensætninger og fremgangsmåder til behandling af mitokondrielle sygdomme | |
GR3036364T3 (en) | Compositions and methods for treating or preventing inflammatory diseases | |
DK0971735T3 (da) | Fremgangsmåder og præparater til behandling af inflammatorisk tarmsygdom | |
NO991676L (no) | FremgangsmÕter og sammensetninger for immunmodulering | |
DK1123313T3 (da) | Fremgangsmåder og sammensætninger til forebyggelse og behandling af anæmi | |
NO20005017D0 (no) | Metoder og viskøse sammensetninger for behandling av brønner | |
DE69926493D1 (de) | Kühleinrichtung und kühlverfahren | |
NO20004896D0 (no) | Pyridazinonhydrokloridforbindelse og fremgangsmÕte for fremstilling derav | |
NO20012963D0 (no) | Fremgangsmåte for fremstilling av 3-alkanoylindoler og 3- alkylindoler | |
NO982265D0 (no) | Diagnostikk for og mediatoter for inflammatoriske forstyrrelser | |
ZA991053B (en) | Method and composition for treatment of inflammatory conditions. | |
DE69941874D1 (de) | Optielektronisches bauelement und herstellungsverfahren | |
NO985385L (no) | Bitumensammensetninger og fremgangsmÕte for fremstilling derav | |
NO20001412D0 (no) | Sammensetninger og fremgangsmåter ved behandling av respiratoriske forstyrrelser | |
DE69924489D1 (de) | Getreide-beta-glukanzusammensetzungen und verfahren | |
FI965008A (fi) | Koostumukset ja menetelmät kasvainten hoitamiseksi | |
ID27214A (id) | Triazolopiridina untuk pengobatan gangguan trombosis | |
NO20010464D0 (no) | Fremgangsmåter og sammensetninger for behandling av gastroösofrageal-reflukssyndrom | |
DE69932573D1 (de) | Wiedergabeverfahren und Wiedergabegerät | |
ATE209195T1 (de) | Naphthylverbindungen und zusammensetzungen | |
EP1064295A4 (en) | METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING CHROMOSOME-18p RELATED DISORDERS | |
NO20022057D0 (no) | Fremgangsmåte og sammensetning for å behandle lungesykdommer | |
PT1051172E (pt) | Metodo para tratamento da dpco |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |